2011 Schedule
Tuesday, July 19

7:30 a.m.-5 p.m. Registration

8:30-10 a.m. Plenary session
PL-03 Plenary 3

PL-03-01 Cognitive ageing and cognitive epidemiology in the Lothian Birth Cohorts of 1921 and 1936
Ian Deary, Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, United Kingdom

PL-03-02 Evaluating Gamma Secretase Inhibitors in a Phase III Trial
Eric Siemers, Eli Lilly and Company, Indianapolis, Ind., United States

PL-03-03 Progression and Transmission of the Lesions in Alzheimer's Disease
Mathias Jucker, Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany

10-10:30 a.m. Break

10 a.m.-5 p.m. Exhibit Hall open

10:30 a.m.-12:30 p.m. Invited Symposia and Featured Research Sessions

S3-01 Genetic and Epidemiological risk factors of Alzheimer's Disease
Chairs: Cornelia van Duijn, Erasmus University Medical Center, Rotterdam, the Netherlands
Lenore Launer, National Institute on Aging, Bethesda, MD, United States

S3-01-01 Epidemiological Studies of Abeta Levels
Christiane Reitz, The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, N.Y., United States

S3-01-02 Atherosclerosis, Aging, Dementia, and Alzheimer Disease
Richard Obrien, Baltimore Longitudinal Study of Aging Cohort, Johns Hopkins Bayview Medical Center, Baltimore, Md, United States

S3-01-03 Dietary Antioxidants and Fat Long-Term Risk of Dementia and Cognitive Decline
Elizabeth Devore, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., United States

S3-01-04 Insulin metabolism and the risk of dementia and Alzheimer disease
Monique Breteler, Erasmus University, Rotterdam, the Netherlands

S3-01-05 Genetic Epidemiological Studies of MRI Pathology - the CHARGE Consortium
Charles DeCarli, University of California, Sacramento, Calif., United States

S3-01-06 Head Circumference, Atrophy, and Cognition: Implications for Brain Reserve in Alzheimer Disease
Alexander Kurz, Department of Psychiatry and Psychotherapy, Klinikum rechts der IsarTechnische Universität München, Munich, Germany

S3-02 New Approaches to Trial Design and Regenerative Therapeutic Targets
Chairs: Inge Grundke-Iqbal, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, N.Y., United States
Mary Sano, Mount Sinai School of Medicine Psychiatry, Bronx, N.Y., United States

S3-02-01 New Designs for Assessing Efficacy in Behavioral Treatments in Alzheimer's Disease
Davangere P. Devanand, New York State Psychiatric Institute, New York, N.Y., United States

S3-02-02 Neural Stem Cell Transplants
Frank LaFerla, Department of Neurobiology and Behavior, University of California Irvine Irvine, Calif., United States

S3-02-03 NGF and Neuronal Plasticity
Antonio Cattaneo, Laboratory of Molecular Mechanisms of Synaptic Plasticity, European Brain Research Institute, Rome, Italy

S3-02-04 gGamma- Secretase and Synaptic Plasticity
Li Yueming, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, N.Y. United States

S3-02-05 CNTF Peptidergic Drugs: A Pharmacological Approach to Enhance Neurogenesis, Neuronal Plasticity and Cognition
Julie Blanchard, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, N.Y., United States

S3-02-06 Small Molecule BDNF Mimetics
Stephen Massa, The University of California, San Francisco, San Francisco, Calif., United States

S3-03 Intraneuronal Aβ Peptide and Progression of Tau Pathology
Chairs: Thomas Bayer, University of Göttingen, Göttingen, Germany
Benoit Delatour, CNRS, Centre de Recherche de l’ICM, Paris, France

S3-03-01 Altered Protein Expression in Pyramidal Neurons in Alzheimer's Disease
Lars Tjernberg, Karolinska Institutet, Alzheimer's Disease Research Center Huddinge, Stockholm, Sweden

S3-03-02 Intracellular Aβ and Neuronal Death
Oliver Wirth, University of Göttingen, Göttingen, Germany

S3-03-03 Functional Correlations of Intracellular Aβ Peptide in Transgenic Mouse Models
Benoit Delatour, CNRS, Centre de Recherche de l'ICM, Paris, France

S3-03-04 Alternative splicing and extracellular tau: the initial steps of tau pathology progression
Fei Liu, Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, N.Y., United States

S3-03-05 Transmission and Spreading of Tauopathy in Transgenic Mouse Brain
Markus Tolnay, Basel University Hospital, Basel, Switzerland

S3-03-06 Tau Pathology in Young People and Its Progression Before Abeta Deposition
Heiko Braak, Center for Clinical Research, University of Ulm, Ulm, Germany

12:30-3 p.m. Poster presentations and lunch on your own

3-5 p.m. Oral presentations

6-10 p.m. Corporate sponsored symposia